Am surprised this is not $100 market cap yet. How many other ASX bio companies able to get complete response for stage 4 cancers in their trials? Not many am aware of. Will not be surprised to see a strategic investor, partner or take over offer soon from one of the big bio players.
Ann: Second Complete Response in ACCENT Pancreatic Cancer Trial, page-5
-
- There are more pages in this discussion • 394 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $93.52M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $1.196M | 5.070M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 413058 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 152093 | 4 |
View Market Depth
| Last trade - 12.57pm 28/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |